Page last updated: 2024-08-23

prednimustine and Preleukemia

prednimustine has been researched along with Preleukemia in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Andersson, M; Pedersen-Bjergaard, J; Philip, P	1

Other Studies

1 other study(ies) available for prednimustine and Preleukemia

Article	Year
High risk of therapy-related leukemia and preleukemia after therapy with prednimustine, methotrexate, 5-fluorouracil, mitoxantrone, and tamoxifen for advanced breast cancer. Cancer, 1990, Jun-01, Volume: 65, Issue:11 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Breast Neoplasms; Female; Fluorouracil; Humans; Leukemia, Myeloid, Acute; Methotrexate; Middle Aged; Mitoxantrone; Prednimustine; Preleukemia; Risk Factors; Survival Rate; Tamoxifen	1990

Article

Year

High risk of therapy-related leukemia and preleukemia after therapy with prednimustine, methotrexate, 5-fluorouracil, mitoxantrone, and tamoxifen for advanced breast cancer.

Cancer, 1990, Jun-01, Volume: 65, Issue:11

Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Breast Neoplasms; Female; Fluorouracil; Humans; Leukemia, Myeloid, Acute; Methotrexate; Middle Aged; Mitoxantrone; Prednimustine; Preleukemia; Risk Factors; Survival Rate; Tamoxifen

1990